← Back to patent-cliff list
CAS 150-13-0
4-Aminobenzoic acid4-aminobenzoic acid
Codes: Tetracaine-022, CONI-017
Application context (from source-drug indications)
AnaesthesiaOxymetazoline Hydrochloride/Tetracaine HydrochloridePeriapical periodontitisOxymetazoline Hydrochloride/Tetracaine HydrochlorideDental cariesOxymetazoline Hydrochloride/Tetracaine HydrochlorideHyponatraemiaConivaptan HydrochlorideAcute decompensated heart failureConivaptan HydrochlorideHeart failureConivaptan HydrochlorideLiver diseaseConivaptan HydrochlorideTraumatic brain injuryConivaptan HydrochlorideKidney diseaseConivaptan HydrochlorideAnaesthesiaTetracaine HydrochlorideRetinitis pigmentosaTetracaine HydrochloridePainTetracaine Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Oxymetazoline Hydrochloride/Tetracaine Hydrochloride | Tier C — Watch / trade | - |
| Conivaptan Hydrochloride | Tier C — Watch / trade | - |
| Tetracaine Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Oxymetazoline Hydrochloride/Tetracaine HydrochlorideOptimised routesteps: 3total yield: 93.5g(Tetracaine)
[1,1'-biphenyl]-2-carboxylic acid→acetimidamide hydrochloride→1-tosyl-1,2,3,4-tetrahydro-5H-benzo[b]azepin-5-one→4-bromo-1-tosyl-1,2,3,4-tetrahydro-5H-benzo[b]azepin-5-one→2-methyl-6-tosyl-1,4,5,6-tetrahydrobenzo[b]imidazo[4,5-d]azepine→4-aminobenzoic acid→4-([1,1'-biphenyl]-2-carboxamido)benzoic acid→pyridine hydrobromide→2-methyl-1,4,5,6-tetrahydrobenzo[b]imidazo[4,5-d]azepine hydrate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.